CIK 0001023024
- Large accelerated filer
ANI PHARMACEUTICALS INC
Sign in to watch- Ticker
- ANIP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 582301143
- Phone
- +1 609-759-1810
- Business address
- 104 CARNEGIE CENTER DRIVE SUITE 300, PRINCETON, NJ, 08540
- Former names
- BIOSANTE PHARMACEUTICALS INC, BEN ABRAHAM TECHNOLOGIES INC
- 4 Exercise or conversion President and CEO acquired 5,000 shares (option exercise)
- 4 Exercise or conversion VP and CFO acquired 4,000 shares (option exercise)
- 4 Exercise or conversion VP Bus Dev & Con Mfg acquired 2,500 shares (option exercise)
- 4 Grant or award President and CEO acquired 15,000 shares (grant or award)
- 4 Grant or award Vice President and CFO acquired 4,200 shares (grant or award)
- 4 Grant or award Director acquired 800 shares (grant or award)
- 4 Grant or award VP Bus Dev & Con Mfg acquired 3,000 shares (grant or award)
- 4 Grant or award Vice President, Operations acquired 1,500 shares (grant or award)
- 4 Grant or award Director acquired 800 shares (grant or award)
- 4 Grant or award Director acquired 800 shares (grant or award)
- 4 Grant or award Director acquired 800 shares (grant or award)
- 4 Grant or award Director acquired 800 shares (grant or award)
- 4 Open-market sale Vice President, Operations sold 15,000 shares at $66.50 ($997,500)
- 4 Open-market sale Director sold 210,000 shares at $63.00 ($13,230,000)
- 4 Open-market sale Vice President and CFO sold 45,000 shares at $63.00 ($2,835,000)
- 4 Open-market sale President and CEO sold 75,000 shares at $63.00 ($4,725,000)
- 4 Open-market sale 10% owner sold 300,000 shares at $63.00 ($18,900,000)
- 4 Open-market sale Director sold 200,000 shares at $63.00 ($12,600,000)
- 4 Open-market buy Director bought 3,000 shares at $27.49 ($82,477)
- 4 Open-market buy President and CEO bought 1,000 shares at $26.50 ($26,500)
Page 26 of 42 · 835 filings